185 related articles for article (PubMed ID: 17025252)
1. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of Ibuprofen.
Tamilvanan S; Sa B
AAPS PharmSciTech; 2006 Sep; 7(3):72. PubMed ID: 17025252
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
Tamilvanan S; Sa B
PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
[TBL] [Abstract][Full Text] [Related]
3. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
4. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
Pargal A; Kelkar MG; Nayak PJ
Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
[TBL] [Abstract][Full Text] [Related]
5. Studies on the in vitro release characteristics of ibuprofen-loaded polystyrene microparticles.
Tamilvanan S; Sa B
J Microencapsul; 2000; 17(1):57-67. PubMed ID: 10670940
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
7. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
8. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
Möller T; Korsatko W
Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic comparison of controlled- and immediate-release formulations of dexibuprofen after single and multiple oral doses in fasting healthy male Korean volunteers.
Noh YH; Lim HS; Cho SH; Ghim JL; Choe S; Jung JA; Kim UJ; Park KM; Jang MJ; Bae KS
Clin Ther; 2011 Sep; 33(9):1132-41. PubMed ID: 21864907
[TBL] [Abstract][Full Text] [Related]
10. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
[TBL] [Abstract][Full Text] [Related]
12. Composite microparticles with in vivo reduction of the burst release effect.
Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P
Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210
[TBL] [Abstract][Full Text] [Related]
13. Formulation development and in vitro evaluation of theophylline microcapsules.
Ahmad M; Akhtar N; Murtaza G; Hussain SW
Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
[TBL] [Abstract][Full Text] [Related]
14. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
Piscitelli DA; Bigora S; Propst C; Goskonda S; Schwartz P; Lesko LJ; Augsburger L; Young D
Pharm Dev Technol; 1998 Nov; 3(4):443-52. PubMed ID: 9834946
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the absorption from three ibuprofen formulations.
Regazzi BM; Rondanelli R; Ciaroelli L; Bartoli AL; Rampini A
Int J Clin Pharmacol Res; 1986; 6(6):469-73. PubMed ID: 3804520
[TBL] [Abstract][Full Text] [Related]
16. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
[TBL] [Abstract][Full Text] [Related]
18. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
Janjikhel RK; Adeyeye CM
J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen-loaded ethylcellulose/polystyrene microspheres: an approach to get prolonged drug release with reduced burst effect and low ethylcellulose content.
Saravanan M; Bhaskar K; Srinivasa Rao G; Dhanaraju MD
J Microencapsul; 2003; 20(3):289-302. PubMed ID: 12881111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
